SecBot SecBot

PBMWW

PSYENCE BIOMEDICAL LTD.
Nasdaq· Pharmaceutical Preparations· Inc. A6· CIK 0001985062 Biotech & Drug Discovery
Warrants of PSYENCE BIOMEDICAL LTD. · PBM stock page →
—
Market cap
$85.0K
Nano cap
Short interest
🔒 Subscribers only
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read MIXED 4 reports · latest
Balance 1 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BULLISH Psyence Biomedical Ltd. has initiated patient dosing in its Phase IIb clinical trial evaluating NPX-5, a…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q4 2025: 1 added (0 new), 1 trimmed or exited.

Who's buying

13F· Q4 2025
0
new positions
0
exits
FundMoveSharesValue
Clear Street Group Inc.TRIM257,209$4.8K
LPL Financial LLCADD49,095$908.00
Walleye Trading LLCADD44,080$635.00
Walleye Capital LLCNEAR_EXIT34,282$494.00

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 5, 2026 SEC
Psyence Biomedical filed an amended equity incentive plan (6-K) to correct a typographical error in Section 4(b) of…
6-K — Impact 2/10
Apr 23, 2026 SEC
Psyence Biomedical Ltd. has initiated patient dosing in its Phase IIb clinical trial evaluating NPX-5, a…
6-K — Impact 7/10
Apr 20, 2026 SEC
Psyence Biomedical Ltd. amended its existing stock purchase agreement with White Lion Capital to introduce a new…
6-K — Impact 6/10
Dec 31, 2025 Inst.
Clear Street Group Inc. — TRIM
257,209 shares ($4.8K)
Dec 31, 2025 Inst.
LPL Financial LLC — ADD
49,095 shares ($908.00)

SecBot reports

4 filings · 1 bullish · 1 bearish · 2 neutral
All PBMWW filing & press-release reports (4)